Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 7.93 M9.56 M9.69 M9.76 M9.06 M9.01 M 37.52 M Research & development —————— — Operating income -575 K-3.47 M1.3 M14.5 M8.13 M10.52 M 34.44 M Non-Operating Income, Total 1.36 M1.46 M1.47 M1.78 M1.53 M1.28 M 6.06 M Interest expense, net of interest capitalized 41.18 M41.42 M42.03 M37.5 M35.2 M36.3 M 151.03 M Non-Operating Income, excl. Interest Expenses -39.81 M-39.96 M-40.56 M-35.73 M-33.67 M-35.02 M -144.98 M Unusual income/expense —————— — Pretax income 10.45 M11.26 M13.61 M16.99 M19.73 M22.3 M 72.62 M Equity in earnings —————— — Taxes 2.85 M3.32 M3.98 M4.83 M5.57 M6.33 M 20.71 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 7.59 M7.94 M9.63 M12.16 M14.15 M15.97 M 51.91 M Discontinued operations —————— — Net income 7.59 M7.94 M9.63 M12.16 M14.15 M15.97 M 51.91 M Dilution adjustment ————00 — Preferred dividends ————0195 K — Diluted net income available to common stockholders 7.59 M7.94 M9.63 M12.16 M14.15 M15.78 M 51.72 M Basic earnings per share (Basic EPS) 0.430.450.550.690.80.89 2.93 Diluted earnings per share (Diluted EPS) 0.430.450.540.690.80.86 2.89 Average basic shares outstanding 17.61 M17.7 M17.58 M17.61 M17.59 M17.72 M — Diluted shares outstanding 17.81 M17.77 M17.69 M17.75 M17.76 M18.63 M — EBITDA 7.43 M6 M10.21 M19.22 M13.8 M15.88 M 59.12 M EBIT 5.98 M4.68 M8.82 M16.99 M12.4 M14.21 M 52.42 M Cost of revenue 4.47 M6.59 M4.79 M7.67 M7.33 M8.09 M 27.88 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 1.46 M1.32 M1.39 M2.23 M1.4 M1.68 M 6.7 M